Background: The purpose of this retrospective study was to identify subcategories in cT3 to cT4a supraglottic/glottic cancers, describing their different spreading patterns, and local and locoregional recurrence modes.
| I NT ROD UCTI ON
The current surgical treatment guidelines for laryngeal cancer in its intermediate/advanced categories distinguish T3 lesions in those amenable to partial versus total laryngectomy. 1 On the other hand, total laryngectomy remains the first therapeutic option for the T4a category, leaving nonsurgical organ preservation protocols for selected patients refusing surgery. Nevertheless, to complicate matters further, a lack of evidence-based clear-cut consensus still exists on how to differentiate patients with T3 to T4a disease amenable to laryngeal conservation surgery from those requiring total laryngectomy. Different factors related to both the tumor and the patient 2, 3 should indeed be considered when making an appropriate selection between patients treatable by the wide spectrum of open partial horizontal laryngectomies (OPHLs) 4 and those requiring intentional organ loss. One possible source of confusion is related to the great heterogeneity of T3 to T4a categories, including a wide gamut of different lesions ranging from T3 with minimal versus massive paraglottic space involvement (with normal or impaired/fixed vocal cord and arytenoid mobility), T3 with preepiglottic space infiltration, T3 with thyroid cartilage erosion, T4 with purely anterior extralaryngeal extension, and T4 with posterior-inferior spreading through the lateral portion of the cricothyroid membrane and the cricothyroarytenoid space. The contemporary endoscopic 5, 6 and imaging 2, 7 workups have dramatically reduced the diagnostic uncertainty level in the pretreatment setting. Notwithstanding this, no endoscopic technique or imaging refinement is as yet able to objectively quantify the degree and causes of reduced/absent motility of the vocal cord/cricoarytenoid unit. 8 Currently, several surgical and nonsurgical options are available for treatment of T3 to T4a laryngeal cancer, with comparable results in terms of locoregional control, overall survival (OS), and laryngectomy-free survival.
9-11 Some large series published by different authors [12] [13] [14] [15] [16] have shown that OPHLs 4 allow sound and reproducible oncologic outcomes to be obtained. Furthermore, these techniques are characterized by a high laryngectomy-free survival, relatively low morbidity and mortality rates, and acceptable functional outcomes, if a careful preoperative patient selection is carried out. The purpose of this multi-institutional retrospective study on patients with T3 to T4a laryngeal cancer treated by OPHLs was to identify, in the vast group of these lesions, some homogeneous subcategories describing their different patterns of spreading and related modes of local and locoregional recurrence.
| P A TI ENT S A ND M ETHO DS

| Patients
After comprehensive preoperative counseling, 479 patients (Table 1) 
| Pathologic T subcategories
Clinical, endoscopic, radiologic, surgical, and pathological reports were retrospectively assessed to divide patients into 4 subcategories based on a laryngeal compartmentalization using a vertical virtual plane tangential to the arytenoid vocal process and perpendicular to the ipsilateral thyroid lamina. We defined anterior and posterior laryngeal compartments as the portions located, respectively, anteriorly or posteriorly to such a plane (see Figure 1 ). The 4 subcategories identified are, therefore, as follows: (1) supraglottic/glottic/subglottic pT3, involving the anterior laryngeal compartment, with PES and anterior PGS involvement with/without inner cortex thyroid infiltration but with normal arytenoid mobility (n 5 233 patients; see Figure 2 ); (2) supraglottic/glottic/subglottic pT3, involving the posterior laryngeal compartment, with infiltration of the whole PGS with/without inner cortex thyroid invasion, and with impaired (reduced or absent) arytenoid mobility (n 5 157 patients; see Figure 3 ); (III) supraglottic/ glottic/subglottic pT4a, involving the anterior laryngeal compartment, with extralaryngeal extension (through the thyrohyoid membrane, thyroid cartilage, and/or cricothyroid membrane) but with normal arytenoid mobility (n 5 60 patients; see Figure 4 ); (IV) supraglottic/glottic/subglottic pT4a, involving the posterior laryngeal compartment, with extralaryngeal extension (through or around the posterior portion of the thyroid lamina, through the lateral cricothyroid membrane, cricoid cartilage, and/or at the level of the cricothyroarytenoid space), and with impaired (reduced or absent) arytenoid mobility (n 5 29 patients; see Figure 5 ). 
| Surgical procedures
| Adjuvant treatments
Based on pathological findings, 62 patients (12.9%) were subjected to adjuvant radiotherapy. The indications were: pN-positive >1 (n 5 43 patients), gross extralaryngeal extension (n 5 17, of whom 6 showed positive margins), and positive margins elsewhere (n 5 2). A large volume encompassing the primary site and all draining lymph nodes were irradiated with a dose of up to 54 Gy. Regions at higher risk for malignant dissemination received a 12 Gy boost (total 66 Gy; range 62-68 Gy). 
| Statistical methods
Clinical, endoscopic, and radiologic follow-up was performed for a mean of 5.3 years (range 6 months to 16.4 years). The OS, disease-free survival (DFS), disease-specific survival (DSS), local control and locoregional control with OPHL alone, laryngectomy-free survival, and laryngoesophageal dysfunction-free survivals 22 were assessed by Kaplan-Meier curves. Log-rank and, for early events, GehanBreslow-Wilcoxon tests were used to compare Kaplan-Meier estimates among the different subcategories. The end points considered were: the date of death (OS); the date of the first recurrence (DFS); the date of death from disease (DSS); the date of the first local recurrence; the date of the first locoregional recurrence; the date of salvage total laryngectomy or the date of death (laryngectomy-free survival); the date of salvage total laryngectomy or the date of tracheostomy and/ or percutaneous endoscopic gastrostomy for functional reasons or the date of death (laryngoesophageal dysfunctionfree survival). The association of prognostic factors for recurrence and subcategories was evaluated by odds ratio, meanwhile the corresponding incidences were compared by chisquare test. All analyses were performed with GraphPad Prism version 6.0e (GraphPad Software, San Diego, CA), with P < .05 as the threshold for statistical significance.
| RES U LTS
| Pathology
Pathology reports showed close margins (<2 mm on the specimen side) in 59 cases (12.3%) and positive margins (negative at frozen sections but positive at the definitive histopathologic examination) in 16 cases (3.3%).
Comparison between clinical and pathological staging showed upstaging of the primary tumor in 73 (15.2%) cT3 lesions that became pT4a (49 in subcategory III and 24 in subcategory IV), whereas 6 cT4a tumors became pT3 (3 in subcategory I and 3 in subcategory II). In total, 428 patients (89.3%) had been classified as cN0. In contrast, 40 (9.3%) of them became pN-positive after neck dissection. Overall, lymph node metastases were detected in 72 patients (15%) of whom 41 (8.6%) had multiple metastases (Table 1) .
| Patterns of failure
In total, 70 patients (14.6%) developed recurrences: 28 (40%) were local, 18 (25.7%) were regional, and 4 (5.7%) were locoregional. Seven patients (10%) had local and distant recurrences, 2 (2.8%) were regional and distant, whereas 10 (14.3%) developed distant metastasis only. One patient (1.4%) developed both locoregional and distant recurrences.
| Survival and disease control according to different subcategories
The 5-year estimates of the abovementioned oncologic outcomes for each subcategory are reported in Table 3 . The OS was significantly higher (P < 0.01; with the log-rank and Gehan-Breslow-Wilcoxon tests) in patients affected by anterior tumors (subcategories I and III, 92.7%) when compared with those treated for posterior ones (subcategories II and IV, 82.3%; Figure 6A ). Moreover, anterior pT3 tumors (subcategory I) had better OS than posterior pT3 tumors (subcategory II, P < .001 with the log-rank and GehanBreslow-Wilcoxon tests), although no significant difference was detected among pT4 tumors (subcategories III vs IV). Finally, OS was hampered by T classification in anterior tumors (subcategories I vs III, P < .01 with the log-rank and Gehan-Breslow-Wilcoxon tests) but not in the posterior ones (subcategories II vs IV).
In the same way, DSS was affected by the described laryngeal compartmentalization: it was 96.3% in anterior tumors (subcategories I and III) and 90.1% in posterior tumors (subcategories II and IV; P < .05 with the log-rank and Gehan-Breslow-Wilcoxon tests; Figure 6B ). A statistically significant difference was also demonstrated when comparing anterior (subcategory I) and posterior (subcategory II) pT3 tumors (P < .05 with the log-rank and GehanBreslow-Wilcoxon tests) but not when analyzing pT4 tumors (subcategories III vs. IV), even though they had a similar trend. Finally, no difference in terms of DSS was detected by comparison of pT3 and pT4 tumors located in the same laryngeal compartment (subcategories I vs III and II vs IV).
The DFS was significantly reduced in posterior tumors (subcategories II and IV, 78.8%) compared with anterior tumors (subcategories I and III, 88.3%; P < .05 with the logrank and Gehan-Breslow-Wilcoxon tests; Figure 6C ). 
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Likewise, posterior pT3 (subcategory II) had worse DFS (P < .05 with the log-rank and Gehan-Breslow-Wilcoxon tests) than anterior pT3 tumors (subcategory I), although no significant difference was detected among subcategories III and IV. Moreover, patients treated for pT4 tumors had more recurrences than those with pT3 neoplasms independently from the anteroposterior localization of the disease (subcategories I vs III, P < .01; subcategories II vs IV, P < .05 with the log-rank and Gehan-Breslow-Wilcoxon tests).
The locoregional control was not significantly different between anterior tumors (subcategories I and III, 88.6%) and posterior tumors (subcategories II and IV, 83.3%; Figure  6D ). Nevertheless, it was better in subcategory I than in subcategory II (P < .05, with the log-rank test), although pT4 Likewise, local control was similar in anterior tumors (subcategories I and III, 92.7%) and posterior tumors (subcategories II and IV, 88.1%; Figure 6E ). Again, subcategory I had better control than subcategory II (P < .05, with the logrank test), whereas no significant difference was detected when comparing pT4 (subcategories III vs IV).
Patients affected by anterior tumors were less prone to fatal outcomes and had less need of salvage total laryngectomy than those with posterior ones (laryngectomy-free survival 90.1% for subcategories I and III and 75.7% for subcategories II and IV; P < .001 with the log-rank test and P < .01 with the Gehan-Breslow-Wilcoxon test; Figure 6F ). Subcategory I had better laryngectomy-free survival than subcategory II (P < .001 with the log-rank and Gehan-Breslow-Wilcoxon tests) but no significant difference was detected between subcategories III and IV. Finally, laryngectomy-free survival was higher in anterior pT3 than in anterior pT4 tumors (P < .01 with the log-rank and Gehan-Breslow-Wilcoxon tests), whereas posterior pT3 had better laryngectomy-free survival with respect to posterior pT4 tumors as an early event only (P < .05 with the Gehan-Breslow-Wilcoxon test).
Similarly, the laryngoesophageal dysfunction-free survival was higher in anterior tumors (subcategories I and III, 88.8%) than in posterior tumors (subcategories II and IV, 74.9%; P < .001 with the log-rank test and P < .01 with the GehanBreslow-Wilcoxon test; Figure 6G ). Again, despite no significant difference being detected between pT4 tumors (subcategories III vs IV), anterior pT3 tumors (subcategory I) had better laryngoesophageal dysfunction-free survival than posterior pT3 tumors (subcategory II, P < .001 with the log-rank and Gehan-Breslow-Wilcoxon tests). Furthermore, only anterior tumors were affected by T classification: anterior pT4 tumors (subcategory III) had worse laryngoesophageal dysfunctionfree survival (P < .001 with the log-rank and Gehan-BreslowWilcoxon tests) than anterior pT3 tumors (subcategory I).
| Correlation between each subcategory and factors affecting locoregional recurrence
The associations between positive or close margins, pNpositive, level VI pN-positive, ECS, and subcategories have been evaluated and results are summarized in Table 4 . Tumor localization was generally associated with the occurrence of ECS alone: its risk of occurrence was indeed higher in posterior tumors (subcategories II and IV) than in anterior tumors (subcategories I and III; P < .05). Despite being not significantly different, the occurrence of ECS seemed to be more frequent in subcategory IV.
The prevalence of positive margins was homogeneous among the subcategories but their occurrence was significantly F IGUR E 6 A, Overall survival; B, disease-specific survival; C, disease-free survival; D, locoregional control; E, local control; F, laryngectomy-free survival; and G, laryngoesophageal dysfunction-free survival for the entire cohort. Log-Rank test: *P < .05; **P < .01; ***P < .001. Gehan-BreslowWilcoxon test: # P < .05; ## P < .01 more frequent in pT4a tumors when compared with pT3 tumors (subcategory III vs I, P < .05; subcategory IV vs II, P < .001). Similarly, no statistically significant difference was detected in terms of pN-positive prevalence among the subcategories but lymph node involvement at level VI was more common in patients affected by pT4a tumors, with respect to those with pT3 tumors (subcategory III vs I, P < .001; subcategory IV vs II, P < .01).
| D IS C US S I ON
The last 2 decades have gradually witnessed a paradigm shift in the treatment of laryngeal cancer, with a progressively increasing significance given to organ and function preservation. [9] [10] [11] 15, 16 Focusing on advanced stages, all the therapeutic approaches, nonsurgical as well as surgical by OPHLs, have demonstrated that larynx preservation is feasible, even though some disappointing long-term results of chemoradiotherapy (CRT) protocols deserve further evaluation and investigation. 9, 23 Despite the undoubted advantages deriving from the laryngeal function preservation approach in terms of quality of life, laryngeal oncology has struggled to develop like other subspecialties in oncology, probably because of the major push toward organ preservation by nonsurgical modalities. In fact, this article clearly demonstrates that excellent results can be obtained even though the application of surgical function sparing strategies like OPHLs maintained that particular accuracy in their indications and limits are observed. From this perspective, the implementation of correct OPHL indications, rather than the surgical technique itself, is probably one of the most important keys to success in this type of surgery.
Assuming that total laryngectomy is the safest treatment for laryngeal cancer in intermediate and advanced stages, any therapeutic approach attempting to preserve the larynx should be based on careful case selection, in which a pivotal role is taken by patient-related and tumor-related parameters. For this reason, meaningful direct comparisons among the oncologic and functional outcomes of CRT, total laryngectomy, and OPHLs are lacking in the current literature for the very reason that they are quite difficult, if not impossible, to be comprehensively made. For the innate diversity (in terms of staging, comorbidity, willingness, age, sex, profession, previous treatments, etc) of those patients considered amenable to one treatment versus another, a true comparison of crude data like survival or swallowing/voice (just to mention the most obvious) is far beyond the real possibilities of any prospective or retrospective analysis.
Because OPHL can be offered to patients as a valuable alternative to preserve part of the larynx and its functions, even in advanced T classifications, avoiding the negative physical and psychosocial impacts of a permanent tracheostomy. 15, 16, 19 After a strict selection of patients (based on the assessment of good general and functional conditions, the absence of clinically positive neck nodes and a good compliance to an intensive rehabilitation protocol), different types of partial laryngectomy can be proposed. When a patient accepts a conservative surgical management approach, in fact, an OPHL type I, IIa, IIb, IIIa, or IIIb may be performed guided by intraoperative evaluations confirmed by frozen section biopsies. This kind of flexibility and customized surgical approach requires specific expertise and, therefore, centralization of such cases in sufficiently large reference centers. Further aspects to be considered during pretreatment multidisciplinary visit are the well-known absolute contraindications to OPHL types II and III, which are based on T and N classificaitons. In our experience, these are represented by: (i) lesions extended to the base of the tongue or pyriform sinus; (ii) lesions with major invasion of PES involving the hyoid bone, lesion involving the interarytenoid space, the posterior commissure, and both arytenoid cartilages; (iii) large extralaryngeal spread of cancer involving the thyroid gland, strap muscles, cervical skin, internal jugular vein, or common carotid artery; and (iv) lesions reaching the first tracheal ring.
The suspected presence of clinically positive nodes >cN1 is not an absolute contraindication. However, it does not represent a good indication to OPHL due to the probable need for postoperative radiotherapy: the first goal of a function-sparing surgical approach should indeed be to get a single-shot therapy.
In the present series, stringent clinical-radiological selection criteria have been adopted to identify homogeneous cT3 and cT4 subcategories that may be treated by OPHL types II and III with the best chance of success. For both supraglottic and glottic T3 and T4 tumors, the most crucial prognosticator seems to be involvement of the posterior PGS, usually associated with reduced mobility or fixation of the ipsilateral arytenoid. This simple criterion of anterior versus posterior laryngeal compartmentalization has herein been demonstrated to be a useful adjunctive parameter to be included in preoperative therapeutic planning.
In fact, when dealing with anterior T3 tumors with normal vocal cord/arytenoid mobility (subcategory I), OPHL compares favorably with transoral laser microsurgery (TLM; whose local control has been shown to be in the range of 44%-72% for glottic and 70%-87% for supraglottic tumors), [24] [25] [26] [27] and with CRT (whose 2-year laryngoesophageal dysfunction-free survival has been reported to be around 40%). 28 The inner thyroid lamina infiltration does not negatively impact on the possibility to attain adequate disease control by such an open-neck conservative approach, although this is definitely the case for TLM and the issue is still debated for CRT. Considering anterior T4 tumors (subcategory III), OPHL allows quite favorable oncologic outcomes that can only be compared with those described after total laryngectomy. Here, the difference is in terms of a better quality of life and function preservation of the larynx. Interestingly, our series highlights that there is not a great difference in terms of OS, DSS, and laryngectomy-free survival between subcategories I and III when these lesions have been addressed by OPHL.
In contrast, the posterior lesions are much more troublesome and definitely represent the most difficult clinical scenario. Posterior T3 tumors with vocal cord/arytenoid fixation (subcategory II) have been shown to offer very poor outcomes when treated by either TLM or CRT. Even using OPHLs, the oncologic outcomes are significantly worse in this subcategory when compared with anterior tumors (OS P < .001, DSS P < .05, and DFS P < .001).
The OPHLs for T3 cancer affecting arytenoid motility requires a detailed knowledge of tumor growth and diffusion patterns. Traditionally, arytenoid fixation was adopted as an exclusion criterion for OPHLs. However, in a study on 77 cases, Katilmis et al 29 focused on the possible different causes of arytenoid fixation: involvement of intrinsic laryngeal muscles with insertion on the arytenoid, cricoarytenoid joint invasion, and recurrent nerve infiltration. Beyond these, another cause of reduced/absent arytenoid mobility is represented by the tumor mass effect, which is present in about 60% of supraglottic lesions. Therefore, an adequate preoperative endoscopic and imaging workup able to reliably distinguish among such different causes of arytenoid fixation is strongly warranted and might greatly help in subclassifying these lesions according to more detailed etiologies in the future. This may also mean that posterior T3 tumors could be considered more similar to T4 from an oncologic as well as from a functional point of view. Even from an anatomic perspective, posterior T3 tumors can present cricoarytenoid joint invasion, cricoid plate infiltration, as well as lateral cricoarytenoid muscle involvement, or perineural spreading along the recurrent nerve. These factors allow tumors to grow outside the laryngeal box, toward the hypopharynx and cervical soft tissues. Once the tumor has gained the thyrocricoarytenoid gateway, it is indeed almost outside the larynx and, in this sense, it is prognostically more similar to T4 cancer. Moreover, in posterior T3 to T4 tumors, the risk of occurrence of lymph nodes with ECS is 2.5 times higher than in anterior lesions, and the occurrence of close margins is 2.4 times higher in anterior pT4 than in pT3, and 8.1 times higher in posterior lesions. In light of this, OPHL should be reserved for very carefully selected cases of posterior T3 (and even less frequently in posterior T4 or subcategory IV) because, even from a functional point of view, OPHL type III 1 removal of one cricoarytenoid unit definitively represents an "extreme" conservative surgery with several technical difficulties and sometimes unpredictable outcomes. Therefore, in posterior T3 to T4 tumors, total laryngectomy (with adjuvant CRT or radiotherapy) should remain the mainstay of treatment.
Another advantage of OPHLs types II and III is their respectable functional outcomes whose occurrences have been summarized in Table 5 . As a matter of fact, use of OPHL allows quite good results to be obtained in terms of the composite end point represented by laryngoesophageal dysfunction-free survival. Even from this point of view, anterior pT3 (subcategory I) had better laryngoesophageal dysfunction-free survival than posterior pT3 tumors (subcategory II, P < .001 with the log-rank and Gehan-BreslowWilcoxon tests).
Recently, comparing CRT versus primary surgery, Timme et al 28 showed that some selected patients with locally advanced laryngeal cancer can be offered nonsurgical organ preservation without compromising survival. However, these have higher rates of laryngeal and esophageal dysfunction than those obtained by OPHLs.
| C ONCL US I ONS
The OPHLs type II and III for intermediate/locally advanced laryngeal cancer provide good oncologic and functional outcomes only if strict patient and tumor selection criteria are followed. Concerning the cT3 category, anterior tumors sparing the posterior PGS and not affecting arytenoid mobility are definitely manageable by such a surgical approach with excellent oncologic outcomes. The OPHLs could also be offered to patients affected by early anterior cT4aN0, strongly motivated to avoid total laryngectomy and declining concurrent CRT. Even though associated with more than promising results, probably due to the strict criteria used to select the subset of patients more suitable for partial laryngectomies, this conservative surgical approach should be carefully applied in cases of cT3 tumors reaching the posterior PGS and causing arytenoid fixation. In fact, the subset of patients belonging to subcategory II comprises tumors characterized by biological behavior as well as oncologic results that seem very similar to those of T4a cancers.
Anyway, a new method of selecting cases amenable to OPHL should first keep in mind the absolute local and general contraindications to this type of surgery. 
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